Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model. Academic Article uri icon

Overview

abstract

  • OBJECTIVE: The purpose of this study was to determine whether treatment with ampicillin together with dexamethasone and indomethacin delays preterm birth that is induced by intraamniotic group B Streptococcus in a nonhuman primate model. STUDY DESIGN: After contraction onset that was induced by group B Streptococcus (10(6) colony-forming units/mL), chronically instrumented rhesus macaques received either no treatment (controls; n = 6); ampicillin (n = 4); or ampicillin + dexamethasone + indomethacin (n = 5). Outcomes included the interval from contraction onset until delivery and concentrations of amniotic fluid inflammatory mediators. RESULTS: Mean interval from contraction onset until delivery was 33 +/- 8.7 hours in controls, 82 +/- 28.0 hours with ampicillin (P = .18, vs controls), and 213 +/- 50.8 hours with ampicillin + dexamethasone + indomethacin (P = .004, vs controls). Ampicillin eradicated group B Streptococcus; however, uterine activity, amniotic fluid cytokines, prostaglandins, and matrix metalloproteinase-9 remained elevated. Ampicillin + dexamethasone + indomethacin suppressed interleukin-1beta, tumor necrosis factor-alpha, and prostaglandins E2 and F2alpha but did not alter matrix metalloproteinase expression or chorioamnionitis. CONCLUSION: The combination of ampicillin + dexamethasone + indomethacin suppressed inflammation and significantly prolonged gestation.

publication date

  • November 1, 2007

Research

keywords

  • Ampicillin
  • Anti-Bacterial Agents
  • Chorioamnionitis
  • Dexamethasone
  • Glucocorticoids
  • Immunologic Factors
  • Indomethacin
  • Obstetric Labor, Premature

Identity

PubMed Central ID

  • PMC2128777

Scopus Document Identifier

  • 35548998285

PubMed ID

  • 17980193

Additional Document Info

volume

  • 197

issue

  • 5